| Companies sponsors |
CSL Behring (garadacimab) |
| Others |
Department of Health and Social Care |
| |
NHS England |
| Patient carer groups |
Action for Children |
| |
Allergy UK |
| |
Anaphylaxis UK |
| |
Asthma and Lung UK |
| |
Genetic Alliance UK |
| |
HAE UK |
| |
Immunodeficiency UK |
| |
Jnetics |
| |
NARA - The Breathing Charity |
| |
National Children’s Bureau |
| |
South Asian Health Foundation |
| |
Specialised Healthcare Alliance |
| |
UK Primary Immune-deficiency Patient Support Charity (UKPIPS) |
| Professional groups |
Association for Respiratory Technology and Physiology |
| |
Association of Genetic Nurses & Counsellors |
| |
Association of Paediatric Emergency Medicine |
| |
British Geriatrics Society |
| |
British Paediatric Allergy, Immunity and Infection Group (BPAIIG) |
| |
British Paediatric Respiratory Society |
| |
British Skin Foundation |
| |
British Society for Allergy & Clinical Immunology |
| |
British Society for Gene and Cell Therapy |
| |
British Society for Genetic Medicine |
| |
British Society for Haematology |
| |
British Society for Immunology |
| |
British Thoracic Society |
| |
BSI Clinical Immunology Professional Network (BSI-CIPN) |
| |
ILD-IN: Interstitial Lung Diseases Interdisciplinary Network |
| |
Immunology and Allergy Nurses Group |
| |
National Heart and Lung Institute |
| |
Neonatal and Paediatric Pharmacists Group |
| |
Primary Care Respiratory Society UK |
| |
Royal College of General Practitioners |
| |
Royal College of Nursing |
| |
Royal College of Paediatrics & Child Health |
| |
Royal College of Pathologists |
| |
Royal College of Physicians |
| |
Royal Pharmaceutical Society |
| |
Royal Society of Medicine |
| |
Royal Society of Medicine - Allergy and Immunology Section |
| |
UK Clinical Pharmacy Association |
| |
UK Forum on Haemoglobin Disorders |
| Associated public health groups |
Public Health Wales |
| |
UK Health Security Agency |
| Comparator companies |
BioCryst Pharmaceuticals (berotralstat) |
| |
CSL Behring (Berinert) |
| |
Maxwellia (tranexamic acid) |
| |
Mylan (tranexamic acid) |
| |
Pharming Group N.V (Ruconest) |
| |
Rivopharm (tranexamic acid) |
| |
Sovereign Medical (tranexamic acid) |
| |
Takeda (Cinryze, lanadelumab) |
| |
Tillomed Laboratories (tranexamic acid) |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
Allied Health Professionals Federation |
| |
Board of Community Health Councils in Wales |
| |
British National Formulary |
| |
Care Quality Commission |
| |
Cell and Gene Therapy Catapult |
| |
Department of Health, Social Services and Public Safety for Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Hospital Information Services – Jehovah’s Witnesses |
| |
Medicines and Healthcare products Regulatory Agency |
| |
National Association of Primary Care |
| |
National Pharmacy Association |
| |
NHS Alliance |
| |
NHS Confederation |
| |
Scottish Medicines Consortium |
| |
Welsh Government |
| |
Welsh Health Specialised Services Committee |
| Relevant research groups |
Asthma, Allergy and Inflammation Research Trust |
| |
British Association for Lung Research |
| |
Cochrane Airways Group |
| |
Cochrane UK |
| |
David Hide Asthma and Allergy Research Centre |
| |
Genomics England |
| |
MRC Clinical Trials Unit |
| |
National Institute for Health Research |